Company Name:REGENXBIO Inc.
CEO: Kenneth T. Mills

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Regenxbio Inc is a biotechnology company. It is engaged in the development, commercialization and licensing of recombinant adeno-associated virus gene therapy.


Key numbers

Market Capitalization:1370237840
Shares Outstanding: 36874000
Float: 33305149.909999996
Next Earning Date:2020-03-10
TTm EPS: -1.7456
TTm Dividend Rate:
200 days moving average:45.38
50 days moving average: 37.49
One day percent Change: 1.35



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,